Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Leukemia, Myeloid, Acute 13 Myeloproliferative Disorders 3 Myelodysplastic Syndromes 3 Cholangiocarcinoma 2 Biliary Tract Neoplasms 2 Recurrence 1 Neoplasm, Residual 1 Neoplasm Metastasis 1 IDH1-Mutated Malignancies 1 Hematologic Neoplasms 1 Anemia, Refractory, with Excess of Blasts 1 AML 1

Interventions

pembrolizumab 49 Specimen Handling 29 Magnetic Resonance Spectroscopy 25 Biopsy 25 Radiosurgery 17 Gemcitabine 17 Nivolumab 16 Cyclophosphamide 14 Cisplatin 14 Paclitaxel 13 Carboplatin 13 Bevacizumab 13 Leucovorin 11 Irinotecan 11 Fluorouracil 11 Drug Therapy 11 Taxes 10 Radiotherapy 10 Oxaliplatin 10 Capecitabine 10 trastuzumab deruxtecan 9 fludarabine 9 cemiplimab 8 Doxorubicin 8 Cetuximab 8 abemaciclib 7 Trastuzumab 7 Pemetrexed 7 Fulvestrant 7 Docetaxel 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Neoplasm Metastasis × ivosidenib × Clear all

NCT06127407 2026-02-06

CHONQUER

Servier

Phase 3 Recruiting

Neoplasm Metastasis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡